1096688-06-0 Usage
Molecular Class
Benzoic acids
Aromatic organic compounds containing a carboxyl group (-COOH) bonded directly to an aromatic ring (a six-membered ring with alternating single and double bonds).
Chemical Structure
Benzoic acid core with a carbon-carbon double bond
The core structure is a benzene ring with a carboxyl group attached, and a carbon-carbon double bond (C=C) is present within the molecule.
Attached Group
Octahydro-1H-4,7-Methanoinden-5-yl)oxy)carbonyl
A complex group consisting of eight hydrogen atoms, a 1H-4,7-Methanoinden-5-yl core, and an oxycarbonyl group (-COO-).
Stereochemistry
3aS, 4S, 5R, 7S, 7aS
The spatial arrangement of the atoms in the molecule, with specific configurations at the 3a, 4, 5, 7, and 7a positions.
Common Uses
Medicinal and pharmaceutical applications
The compound is used in the development of drugs and treatments due to its potential therapeutic properties.
Biological Activities
Anti-inflammatory, analgesic, or other activities
The compound may exhibit various biological effects, such as reducing inflammation, relieving pain, or other beneficial actions.
Context-dependent effects
Uses and effects depend on the specific context and formulation
The precise applications and effects of the compound may vary depending on the conditions in which it is used and the form it takes (e.g., as a pure substance, in combination with other compounds, or as part of a drug formulation).
Check Digit Verification of cas no
The CAS Registry Mumber 1096688-06-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,6,6,8 and 8 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1096688-06:
(9*1)+(8*0)+(7*9)+(6*6)+(5*6)+(4*8)+(3*8)+(2*0)+(1*6)=200
200 % 10 = 0
So 1096688-06-0 is a valid CAS Registry Number.
1096688-06-0Relevant articles and documents
STEREOISOMERS OF TRICYCLODECAN-9-YL-XANTHOGENATE
-
Page/Page column 68-69, (2009/03/07)
Provided herein are optically active stereoisomers of tricylclodecan-9-yl xanthogenate, processes of preparation, and pharmaceutical compositions thereof. Also provided are methods of their use for treating, preventing, or ameliorating one or more symptoms of a disease caused by a virus.